R&D key to pharma sector: Harney
Europe faces paying a heavy price if the continued fall-off in R&D investment by the pharmaceutical industry within the European Union is allowed to continue unchecked, the Tánaiste Mary Harney said today.
Job losses and reduced economic activity will be the end result, she added.





